Resultado del tratamiento hipouricemiante de la gota en ancianos

Pérez Ruiz, Fernando; Ruibal Escribano, Ana; Calabozo Raluy, Marcelo; Herrero Beites, Ana María.
Rev. esp. reumatol. (Ed. impr.) ; 28(8): 321-324, oct. 2001.
Artículo en Es | IBECS (España) | ID: ibc-3188

Documentos relacionados

  1. The Development of Gout Treat-To-Target booklet.
  2. [Recent advances in gout: pathogenesis, diagnosis, comorbidities, treatment].
  3. The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.
  4. Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update.
  5. Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study).
  6. Uricosuric medications for chronic gout.
  7. The Utility of the Random Urine Uric Acid-to-Creatinine Ratio for Patients with Gout Who Need Uricosuric Agents: Retrospective Cross-Sectional Study.
  8. Major unanswered questions in the clinical gout field.
  9. Update on emerging urate-lowering therapies.
  10. Comparison of the efficacy of febuxostat vs. benzbromarone in the treatment of gout: a meta-analysis in Chinese gout patients.